Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Le Phos. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel synthesis method for N-N axis chiral compounds delivering high ee and mild conditions. Reliable supplier for pharma intermediates ensuring cost reduction.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Patent CN114315536A reveals a metal-free method for synthesizing axial chiral diarylethenes with high enantioselectivity, offering significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand synthesis offering superior stereoselectivity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN110452150A reveals efficient synthesis of axial chiral indole-naphthalene compounds. Offers cost reduction in specialty chemical manufacturing and reliable supply chain solutions.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN102040564B reveals a safe, high-yield nucleophilic substitution route for 3-aminobenzo[d]isothiazole, offering significant cost reduction and supply chain stability for pharma manufacturing.
Patent CN114524701B details a novel chiral phosphoric acid catalyzed synthesis of N-N axis chiral pyrroles with high enantioselectivity and cytotoxic activity.
Novel organocatalytic synthesis of axially chiral 1-aryl indoles via spirophosphoric acid. Offers mild conditions and high enantioselectivity for glioma drug development.
Patent CN111848322B details a chiral phosphoric acid catalyzed resolution method for axially chiral oxindole-styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles. High yield, mild conditions, suitable for pharmaceutical intermediate manufacturing.
Novel chiral phosphoric acid catalyzed synthesis of N-N axis pyrroles with high enantioselectivity for anticancer drug development and pharmaceutical intermediates.
Discover the novel N-N axis chiral bis-indole phosphine ligand from patent CN116041393B. Offers superior stereoselectivity for asymmetric catalysis and cost-effective manufacturing.
Novel N-N axis chiral ligand synthesis via organocatalysis. High enantioselectivity for pharma intermediates. Cost-effective scalable route for complex molecule manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Novel synthesis method patent CN116199614B offers high enantioselectivity and cost reduction in pharmaceutical intermediates manufacturing for global supply chains.
Patent CN111848322B details a novel chiral phosphoric acid resolution method for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN116041393B reveals a novel N-N axis chiral bis-indole phosphine ligand offering superior stereoselectivity for asymmetric allylation and cost-effective pharmaceutical intermediate manufacturing.